...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Hepatic abscess after liver transplantation: 1990-2000.
【24h】

Hepatic abscess after liver transplantation: 1990-2000.

机译:肝移植后肝脓肿:1990-2000年。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Infections following solid-organ transplants are a major cause of morbidity and mortality. Few studies have reported the complications of hepatic abscesses. METHODS: This investigation consisted of a retrospective chart review of all solid-organ transplant recipients from 1990 to 2000. Criteria for diagnosis included parenchymal hepatic lesions, positive cultures from liver aspirates or blood cultures, or both, and a compatible clinical presentation. RESULTS: Of 2,175 recipients of all organ transplants (heart, lung, kidney, liver, pancreas), we identified 12 patients who had experienced 14 episodes of hepatic abscess, all in liver transplant recipients. Median time from transplant to hepatic abscess was 386 days (range 25-4,198). The most common predisposing factor was hepatic artery thrombosis (HAT), which occurred in eight patients, and was diagnosed at an average of 249 days (range 33-3,215) after transplantation. Clinical presentation of hepatic abscess was similar to that described innon-immunosuppressed patients. All but one patient showed hypoalbuminemia (<3.5 g/dL); those with HAT also had significantly elevated lactate dehydrogenase. Liver aspirates grew gram-positive aerobic bacteria (50% of isolates), gram-negative aerobic bacteria (30%), and anaerobes and yeasts (10% each). Patients received an average of 6 weeks of intravenous antibiotic therapy. Catheter drainage was successful in 70% of cases; and five patients required retransplantation. Altogether, five of the patients died, yielding a mortality rate of 42%. CONCLUSIONS: Hepatic abscess, a rare complication after liver transplantation, was frequently associated with hepatic artery thrombosis. Mortality was higher than in patients who had not undergone transplantation. Prolonged antibiotic therapy, drainage, and even retransplantation may be required to improve the outcome in these patients.
机译:背景:实体器官移植后的感染是发病率和死亡率的主要原因。很少有研究报道肝脓肿的并发症。方法:本研究包括对1990年至2000年所有实体器官移植受者的回顾性图表回顾。诊断标准包括肝实质实质病变,肝穿刺阳性培养物或血液培养物或两者兼有,以及符合临床要求。结果:在所有器官移植(心脏,肺,肾,肝,胰腺)的2175位接受者中,我们鉴定出12位经历了14次肝脓肿发作的患者,全部来自肝脏移植接受者。从移植到肝脓肿的中位时间为386天(范围25-4198)。最常见的诱发因素是肝动脉血栓形成(HAT),发生在八名患者中,在移植后平均被诊断为249天(范围33-3,215)。肝脓肿的临床表现与非免疫抑制患者相似。除一名患者外,所有患者均出现低白蛋白血症(<3.5 g / dL);那些患有HAT的人的乳酸脱氢酶也明显升高。肝吸出液中生长有革兰氏阳性需氧菌(占分离菌的50%),革兰氏阴性有氧菌(占30%),厌氧菌和酵母菌(各占10%)。患者平均接受了6周的静脉抗生素治疗。 70%的病例成功进行了导管引流。五名患者需要重新移植。共有五名患者死亡,死亡率为42%。结论:肝脓肿是肝移植后罕见的并发症,通常与肝动脉血栓形成有关。死亡率高于未接受移植的患者。可能需要延长抗生素治疗,引流甚至再移植以改善这些患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号